Prelude Capital Management, LLC Igm Biosciences, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$3.94 - $8.79 $30,732 - $68,562
-7,800 Reduced 20.96%
29,421 $244,000
Q3 2023

Nov 14, 2023
BUY
$6.66 - $10.64 $116,856 - $186,689
17,546 Added 89.18%
37,221 $310,000
Q2 2023

Aug 14, 2023
BUY
$8.86 - $14.0 $174,320 - $275,450
19,675 New
19,675 $181,000

Others Institutions Holding IGMS

# of Institutions
82
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $49M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email